Ticker Symbol: NTEC
Intec Pharma Ltd. - Ordinary Shares
Exchange: NASDAQ CAPITAL MARKET
Country:
Israel
Company Profile
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 12 Hartom Street
Website: intecpharma.com
CEO: Jeffrey Meckler
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $9.59 - $11.09
Beta: 1.17
52wk. High: $36.79
52wk. Low: $8.80
Ytd. Change -30.22%
50 Day Moving Average: $13.50
200 Day Moving Average: $16.48
Shares Outstanding: 7370883
Valuation
Market Cap: 7.1B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A